Lifestyle interventions for sarcopenic obesity in polycystic ovary syndrome

  • Philip D. Chilibeck
  • , Maryam Kazemi
  • , Laura E. McBreairty
  • , Gordon A. Zello

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is characterized by a combination of hyperandrogenism, ovulation dysfunction, and/or polycystic ovarian morphology. Low muscle mass relative to fat mass, described as "sarcopenic obesity, " is a condition which leads to metabolic disorders to a greater degree than either sarcopenia or obesity alone. About 58% of women with PCOS have sarcopenic obesity; this may contribute the high degree of metabolic disorders (i.e., hyperglycemia, hyperinsulinemia, dyslipidemia). Diets designed to improve risk factors for cardio-metabolic disease (DASH, Mediterranean, Portfolio, low-glycemic index, low-carbohydrate diets), as well as supplements (vitamin D, omega-3 fatty acids, antioxidants, carnitine) have potential to be effective for women with PCOS. Low-moderate intensity aerobic training or high-intensity interval training combined with resistance training improves metabolic aberrations as well. Women with PCOS should be offered a wide variety of effective interventions to choose from since adherence to any one intervention tends to be low.

Original languageEnglish
Title of host publicationObesity and Diabetes
Subtitle of host publicationScientific Advances and Best Practice
PublisherSpringer International Publishing
Pages907-920
Number of pages14
ISBN (Electronic)9783030533700
ISBN (Print)9783030533694
DOIs
StatePublished - 14 Dec 2020
Externally publishedYes

Keywords

  • Androgens
  • Fat
  • Glucose
  • Insulin
  • Lipids
  • Muscle
  • Testosterone

Fingerprint

Dive into the research topics of 'Lifestyle interventions for sarcopenic obesity in polycystic ovary syndrome'. Together they form a unique fingerprint.

Cite this